How GLP-1 treatment and hormone replacement therapy (HRT) support each other Jacqueline Raposo Dr
DS: Funding acquisition, Project administration, Resources, Supervision, Writing review & editing
These studies were soon followed by a number of phase 2 and phase 3 clinical trials with several different DPP-4 inhibitors, all essentially showing that DPP-4 inhibition was a safe and well-tolerated means of improving glycaemic control in patients with T2DM
#Pharma #ObesityCare #GlobalHealth #Partnerships #CGXPwire cGxP.wire To view or add a comment, sign in More Relevant Posts NRx Pharmaceuticals Advances NRX-100 Toward NDA NRx Pharmaceuticals, Inc
Journal of Orthopaedic Surgery and Research (2019)
Whats not included: Lab work, but they now have a Noom Proactive Health Microdosing GLP-1Rx Program, where they include an easy at-home biomarker test kit starting at $149